232 related articles for article (PubMed ID: 21677151)
1. Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells.
Alvero AB; Montagna MK; Holmberg JC; Craveiro V; Brown D; Mor G
Mol Cancer Ther; 2011 Aug; 10(8):1385-93. PubMed ID: 21677151
[TBL] [Abstract][Full Text] [Related]
2. NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway.
Alvero AB; Montagna MK; Chen R; Kim KH; Kyungjin K; Visintin I; Fu HH; Brown D; Mor G
Cancer; 2009 Jul; 115(14):3204-16. PubMed ID: 19472400
[TBL] [Abstract][Full Text] [Related]
3. 18β-glycyrrhetinic acid potentiates Hsp90 inhibition-induced apoptosis in human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathway.
Yang JC; Myung SC; Kim W; Lee CS
Mol Cell Biochem; 2012 Nov; 370(1-2):209-19. PubMed ID: 22865487
[TBL] [Abstract][Full Text] [Related]
4. Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines.
Jang ER; Kim YJ; Myung SC; Kim W; Lee CS
Mol Cell Biochem; 2011 Jul; 353(1-2):1-11. PubMed ID: 21380726
[TBL] [Abstract][Full Text] [Related]
5. Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway.
Lee CS; Jang ER; Kim YJ; Myung SC; Kim W; Lee MW
Invest New Drugs; 2012 Apr; 30(2):548-57. PubMed ID: 21120579
[TBL] [Abstract][Full Text] [Related]
6. Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer.
Xue J; Li R; Zhao X; Ma C; Lv X; Liu L; Liu P
Chem Biol Interact; 2018 Mar; 283():59-74. PubMed ID: 29421517
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.
Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748
[TBL] [Abstract][Full Text] [Related]
8. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
[TBL] [Abstract][Full Text] [Related]
9. Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors.
Alvero AB; Montagna MK; Sumi NJ; Joo WD; Graham E; Mor G
Oncotarget; 2014 Sep; 5(18):8703-15. PubMed ID: 25237928
[TBL] [Abstract][Full Text] [Related]
10. Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.
Zou J; Wang Y; Liu M; Huang X; Zheng W; Gao Q; Wang H
Cell Biochem Funct; 2018 Aug; 36(6):303-311. PubMed ID: 29984416
[TBL] [Abstract][Full Text] [Related]
11. Guanylate cyclase activator YC-1 potentiates apoptotic effect of licochalcone A on human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathways.
Lee CS; Kwak SW; Kim YJ; Lee SA; Park ES; Myung SC; Kim W; Lee MS; Lee JJ
Eur J Pharmacol; 2012 May; 683(1-3):54-62. PubMed ID: 22465181
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
[TBL] [Abstract][Full Text] [Related]
14. TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence.
Chefetz I; Alvero AB; Holmberg JC; Lebowitz N; Craveiro V; Yang-Hartwich Y; Yin G; Squillace L; Gurrea Soteras M; Aldo P; Mor G
Cell Cycle; 2013 Feb; 12(3):511-21. PubMed ID: 23324344
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of Hsp90 inhibitor geldanamycin and parthenolide via reactive oxygen species-mediated apoptotic process on epithelial ovarian cancer cells.
Lee CS; Kim YJ; Lee SA; Myung SC; Kim W
Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):173-81. PubMed ID: 22433057
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors.
Sheppard KE; Cullinane C; Hannan KM; Wall M; Chan J; Barber F; Foo J; Cameron D; Neilsen A; Ng P; Ellul J; Kleinschmidt M; Kinross KM; Bowtell DD; Christensen JG; Hicks RJ; Johnstone RW; McArthur GA; Hannan RD; Phillips WA; Pearson RB
Eur J Cancer; 2013 Dec; 49(18):3936-44. PubMed ID: 24011934
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mitochondrial translation as a therapeutic strategy for human ovarian cancer to overcome chemoresistance.
Hu B; Guo Y
Biochem Biophys Res Commun; 2019 Feb; 509(2):373-378. PubMed ID: 30591219
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells.
Decollogne S; Joshi S; Chung SA; Luk PP; Yeo RX; Nixdorf S; Fedier A; Heinzelmann-Schwarz V; Hogg PJ; Dilda PJ
Gynecol Oncol; 2015 Aug; 138(2):363-71. PubMed ID: 26080289
[TBL] [Abstract][Full Text] [Related]
19. Dendrobium officinale polysaccharide triggers mitochondrial disorder to induce colon cancer cell death via ROS-AMPK-autophagy pathway.
Zhang K; Zhou X; Wang J; Zhou Y; Qi W; Chen H; Nie S; Xie M
Carbohydr Polym; 2021 Jul; 264():118018. PubMed ID: 33910741
[TBL] [Abstract][Full Text] [Related]
20. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma.
Bartakova A; Michalova K; Presl J; Vlasak P; Kostun J; Bouda J
J Obstet Gynaecol; 2018 Jan; 38(1):110-114. PubMed ID: 28816557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]